The role of cocrystals in pharmaceutical science.
By N. Shan, M. Zaworotko. Drug Discovery Today, 2008
708 citations recorded by the source corpus.
Subfields: Materials Chemistry, Mechanics of Materials, Physical and Theoretical Chemistry
View Paper: https://www.semanticscholar.org/paper/5eae9b0061eb6ec1472addcef24cd05c79eeed94
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Materials Chemistry
- Christopher J. H. Porter
- W. Charman
- S. Charman
- H. Williams
- R. Shanker
- Natalie L. Trevaskis
- Colin W. Pouton
- A. Gajjar
Citations in the corpus
- Strategies to Address Low Drug Solubility in Discovery and Development (2013, background): “Synthon selection during cocrystal design has been aided significantly by large number of cocrystal structures listed in the Cambridge Structural Database (Allen, 2002; Shan and Zaworotko, 2008).”
- Drug Solubility: Importance and Enhancement Techniques (2012, background): “These are prepared by slow evaporation from a drug solution containing stoichiometric amounts of the components (cocrystal formers); however, sublimation, growth from the melt, or grinding of two or more solid cocrystal formers in a ball mill are also suitable methodologies [65].”